Press release
Trialreach Secures $1.2m in Funding to Expand its Discovery Platform for Clinical Trials and Patient Recruitment Services
TrialReach is a groundbreaking service that helps patients with any medical condition to explore, understand and access the latest clinical trials, anywhere in the world.London, UK, October 27, 2011 -- TrialReach is a groundbreaking service that helps patients with any medical condition to explore, understand and access the latest clinical trials, anywhere in the world. The Internet and social media have enabled patients to become much more deeply involved in managing their own diseases and there has been an explosion of online information. However, the information about new treatments and clinical trials has remained, until now, obscure and inaccessible for the majority of those patients looking online for help. At the same time, every day, thousands of new patients are needed in projects designed to prove the effectiveness of new medical treatments and devices. TrialReach’s unique website combines a specialised search engine, exclusive patient-friendly information and fast communication channels between patients and physicians to make clinical trials easy to find, easy to understand, and easy to access.
“Our strategy is based on empowering patients through content, tools and context, a formula that has revolutionized other sectors but was never tried before in clinical trials. The results so far have greatly exceeded our initial expectations. Thousands of patients have signed up for studies through our website, and hundreds of them have been put in contact with the investigators after passing a strict triple-filter process”, said Pablo Graiver, co-founder and CEO of TrialReach.
UK technology investor Amadeus Capital Partners Ltd. recently led an investment of $1.2 million in the company to further develop the TrialReach platform with the addition of new tools and content for patients and clinical trial sponsors, and to enable the expansion their services to other languages and territories around the world. Alex van Someren, General Partner in the Amadeus & Angels Seed Fund, said: “I was impressed from the outset by the importance of what TrialReach does in quickly connecting patients with treatments which could help them. Even better, the company was founded by a team with real experience in building successful technology businesses. I’m genuinely excited about the potential for TrialReach to improve people’s lives, save trial sponsors time & money, and build a global business for our investors.”
TrialReach works closely with investigators and clinical trial sponsors, including global pharmaceutical companies, biotech companies and clinical recruitment organisations (CROs), to create fresh online multimedia descriptions of the studies, as well as their accompanying user-friendly pre-screening questionnaires. The solution includes a feature that gives patients the option to forward their own questions to healthcare professionals, usually the actual investigators of each study. Jessica Mann MD PhD, co-founder and Chief Medical Officer of TrialReach, noted: “The benefits of TrialReach’s tools, both to patients and to the industry, can be quite literally life-changing. I have experienced the patient recruitment problem first-hand for many years and for the first time I believe that through TrialReach there is a real, lasting solution that is friendly, efficient and extremely cost-effective.”
TrialReach is presenting at the Health 2.0 Europe Conference (http://www.health2con.com/europe/) in Berlin, 27-28th October 2011, where the company will be unveiling their new website to the public.
About TrialReach Ltd.
Headquartered in London, England, TrialReach is a global search and referral engine for clinical trials, dedicated to making clinical trials easy to find out about, understand, and get access to. TrialReach uses the latest online technologies and marketing tools to bridge the gap between patients wanting to take part in clinical trials and sponsors and investigators seeking to recruit participants. For more information about the company, visit http://www.trialreach.com.
Headquartered in London, England, TrialReach is a global search and referral engine for clinical trials, dedicated to making clinical trials easy to find out about, understand, and get access to.
Contact:
Pablo Graiver
CEO
TrialReach Ltd
London, UK
+44(0)79200-45654
pablo@trialreach.com
http://www.trialreach.com
http://twitter.com/#!/trialreach
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trialreach Secures $1.2m in Funding to Expand its Discovery Platform for Clinical Trials and Patient Recruitment Services here
News-ID: 198037 • Views: …
More Releases for London
Queens Tantric Massage London Expands Practitioner Network in Central London
Image: https://www.globalnewslines.com/uploads/2025/08/1755168437.jpg
Queens Tantric Massage London connects clients with vetted practitioners offering therapeutic tantric massage across Central London.
LONDON, UK - Queens Tantric Massage London [https://queenstantricmassage.co.uk/], a professional tantric massage agency, has announced an expansion of its network of independent masseuses operating across Central London.
The agency connects clients with qualified practitioners who either work from their own private studios in locations such as Kensington, Hyde Park, and Soho, or who offer outcall…
London Scaffolding Company Expands Services to North London
Maddison Scaffolding Ltd has officially expanded its trusted scaffolding services to cover the North London area, providing safe, reliable, and fully compliant access solutions for residential, commercial, and construction projects.
Founded in Epsom, Maddison Scaffolding has earned a strong reputation in South West London and Surrey for its commitment to safety, professionalism, and outstanding customer service. This new expansion will allow the company to serve boroughs including Camden, Islington, Barnet, and…
London Lux: Discover the Best Nightclubs in London this summer
Image: https://www.getnews.info/wp-content/uploads/2024/08/1723619860.jpeg
As the summer heat intensifies, London's nightlife [https://luxguestlist.com/en] scene is heating up with an array of vibrant nightclubs offering unforgettable experiences. From world-renowned venues to hidden gems, the city is pulsing with energy, making it the ultimate destination for night owls and party enthusiasts. For those seeking a more exclusive experience, London VIP tables [https://luxguestlist.com/en/vip-tables] are available at these top venues, offering VIP bottle service and a premier party…
London Backpackers for Cheapest Hostel Stay in London - Cut the Cost of a Stay i …
London is a fantastic place to visit at any time of the year, but there’s really no getting away from the fact that a trip can be expensive. The good news for travelers from all over the world is that they can bring those costs down and still enjoy a fantastic visit if they book a stay at the London Backpackers hostel. The hostel is located in the heart of…
The Man Van in London Makes Moving In London More Affordable
The London removal company has become one of the most recommended home and office removal services.
London continues to be the most expensive place to purchase a home in the UK with the average price of a property costing £473,073. However, it’s not just the cost of purchasing or renting a home that can be expensive, moving in and around London can be more expensive than other areas of the UK.…
London 2012
Off to the Paralympics with 15,000 spare parts
Ottobock, the medical equipment company, is preparing for a large-scale operation at the Paralympic Games in London (29 Aug. to 9 Sept. 2012). Some 4,200 athletes are expected at the second largest sports event in the world. In order to ensure technical service for them, Ottobock is sending 78 orthopaedic technicians from 20 countries. The first vehicles are already transporting 9…
